삼성제약: directors' dealings · South Korea · DART (FSS)

Explore the full management transaction log of 삼성제약, a publicly traded company based in South Korea. Shares trade on KR KR, under the supervision of DART (FSS). Operating in the Healthcare sector, 삼성제약 has recorded 1 insider filings. Market capitalisation: €159.1bn. The latest transaction was disclosed on 11 March 2026 — Other. Among the most active insiders: 삼성제약. All data is accessible without an account.